Special: 5 Pro Tricks to Make Huge Returns in the Market



EBS: Emergent BioSolutions, Inc. is a Buy

The current rating for EBS is 87, which is 74% above its historic median rating of 50. This indicates lower risk than normal.

The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.